Dr Najer is currently a Lecturer in Pharmaceutical Advanced Therapies at the Institute of Pharmaceutical Science at King’s College London. He previously obtained a BSc (2009) and MSc (2011) in Nanosciences at the University of Basel, Switzerland, with one exchange semester conducted at Lund University in Sweden. He subsequently finished his PhD (2016) in Nanosciences at the Department of Chemistry at the University of Basel in Switzerland (Prof. Wolfgang Meier and Prof. Cornelia Palivan) and in collaboration with the Swiss Tropical and Public Health Institute (Swiss TPH, Prof. Hans-Peter Beck).

After conducting two postdoctoral fellowships (SNSF Early Postdoc Mobility and Sir Henry Wellcome Postdoctoral Fellowship) across the Department of Materials, Department of Life Sciences, Department of Bioengineering, and the Institute of Biomedical Engineering at Imperial College London, UK (Prof. Molly Stevens and Prof. Jake Baum), he was appointed as a Lecturer (2023) in Pharmaceutical Advanced Therapies at King’s College London, UK.

His current research interests include anti-pathogenic nanotherapeutics, manipulating nanoparticle surface-protein interactions, and cell-mediated nanomedicine delivery. For his PhD work, Dr Najer has received the Award for the Best PhD Thesis of the Faculty of Science of the University of Basel 2017. He then successfully applied for two independent postdoctoral fellowships conducted at Imperial College London (SNSF, 1.5y and Wellcome Trust, 4y).

His supervision efforts were recognised with the Imperial College London President’s Award for Excellence in Education: Outstanding Assistant Supervisor 2020.